ArticleCell death & disease2020

Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance.

Clara Alcon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.